Business Insider24d
Oliveda International, Inc. (OLVI) Announces Over $100 Million in Net Revenue for Olive Tree People Inc. Subsidiary in Its Second Year in the U.S.
Santa Monica, California, March 03, 2025 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced ... award-winning extra virgin olive oils, the extraction of ...
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support ...
WPRI 121mon
Oliveda International, Inc. (OLVI) Announces Over 1,000% January 2025 Growth for Olive Tree People Inc. Subsidiary
SANTA MONICA, CA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced ... award-winning extra virgin olive oils, the extraction of hydroxytyrosol ...
Hosted on MSN1mon
Earnings call transcript: Olvi Group reports strong 2024 growth, stock dips
Olvi Group's earnings call for Q4 2024 revealed continued growth, marking the ninth consecutive year of expansion. Despite this, the company's stock saw a decline of 2.88% following the announcement.
Yahoo Finance2d
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced ...
WAVY-TV23d
Oliveda International, Inc. (OLVI) Announces Over $100 Million in Net Revenue for Olive Tree People Inc. Subsidiary in Its Second Year in the U.S.
LOS ANGELES, March 4, 2025 /PRNewswire/ -- Oliveda International, Inc. (OTC Pink: OLVI) today announced that ... With an efficacy 3,000 times greater than olive oil, this elixir reflects the ...
Yahoo Finance2d
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
- U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support traditional approval- WESTLAKE VILLAGE, Calif.
manilatimes24d
Oliveda International, Inc. (OLVI) Announces Over $100 Million in Net Revenue for Olive Tree People Inc. Subsidiary in Its Second Year in the U.S.
Santa Monica, California, March 03, 2025 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced that its Olive ... internationally award-winning extra virgin olive oils, the ...